Larimar Therapeutics (STU:ZA71) 3-Year Book Growth Rate : -31.70% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Larimar Therapeutics 3-Year Book Growth Rate?

Larimar Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €3.33.

During the past 12 months, Larimar Therapeutics's average Book Value per Share Growth Rate was 47.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was -31.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 5 years, the highest 3-Year average Book Value per Share Growth Rate of Larimar Therapeutics was -31.70% per year. The lowest was -31.70% per year. And the median was -31.70% per year.

Competitive Comparison of Larimar Therapeutics's 3-Year Book Growth Rate

For the Biotechnology subindustry, Larimar Therapeutics's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Larimar Therapeutics's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Larimar Therapeutics's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Larimar Therapeutics's 3-Year Book Growth Rate falls into.

Larimar Therapeutics 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Larimar Therapeutics (STU:ZA71) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Larimar Therapeutics 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Larimar Therapeutics's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Larimar Therapeutics (STU:ZA71) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Larimar Therapeutics Inc (STU:ZA71) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

LRMR:USA

Address

Three Bala Plaza East, Suite 506, Bala Cynwyd, PA, USA, 19004

Website

https://www.larimartx.com

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Larimar Therapeutics (STU:ZA71) Headlines

No Headlines